October 30, 2026
October 30, 2026
Monthly fasting cycles may be feasible in T2D
October 30, 2026
Top 10 evidence-based essentials in ObGyn
October 30, 2026
High TIRADS may signal cancer despite benign cytology
October 27, 2026
FDA expands talazoparib use in prostate cancer
October 27, 2026
Inside the $10 Optical Spectrometer
Latest Headlines
View More
October 30, 2026
FDA revises warnings on 3 estradiol patches
October 30, 2026
Monthly fasting cycles may be feasible in T2D
October 30, 2026
Top 10 evidence-based essentials in ObGyn
October 30, 2026
High TIRADS may signal cancer despite benign cytology
October 27, 2026
FDA expands talazoparib use in prostate cancer
October 27, 2026
Inside the $10 Optical Spectrometer
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Conference Coverage
2026 AAO
October 01, 2026
Elegrobart Meets Phase 3 Primary Endpoint in TED
2026 AAO Meeting
September 23, 2026
Topcon Launches Oku Digital Health at AAO
2026 Retina Society Meeting
September 23, 2026
Sura-vec Shows Durable Effect at 3 Years
Clinical Guidelines
View More
October 06, 2026
ACP puts hormone therapy first for menopause symptoms
August 11, 2026
CHEST Issues OSA Guidance for Pregnancy
July 06, 2026
ACP Ranks Obesity Drug Options
Commentary & Perspectives
View More
June 27, 2026
GLP-1 Drugs Tied to Smell, Taste Changes
June 23, 2026
Side Effects: Sour Mouth, Lower BP
June 17, 2026
Peptides Are Outrunning the Rulebook
June 10, 2026
Another Point of View: Reefer Madness!
FDA & Government News
View More
October 30, 2026
FDA revises warnings on 3 estradiol patches
October 27, 2026
FDA expands talazoparib use in prostate cancer
October 26, 2026
FDA expands weekly insulin use to children
October 21, 2026
FDA clears new generic weekly menopause patch
Business Management
View More
August 27, 2026
10 states that support physician work-life balance
